TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23525044

Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 21348963

Group type: EXPERIMENTAL
Intervention: Hand-held dynamic contour tonometer (HH-DCT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Perkins applanation tonometer (PAT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: TonoPenXL (TPXL)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Comparison of IOP range between devices
Number of subjects: 92
Study: 19481750

Group type: EXPERIMENTAL
Intervention: Kegel exercises
Number of subjects: 240

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 240
Study: 16562586

Group type: EXPERIMENTAL
Intervention: Adolescents with DM2
Number of subjects: 57
Study: 12972745

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 4465

Group type: COMPARATOR
Intervention: Intravenous meperidine analgesia
Number of subjects: 4465
Study: 11193131

Group type: EXPERIMENTAL
Intervention: CEE 0.3 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: CEE 1.25 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 9590932

Group type: EXPERIMENTAL
Intervention: Occlusal splint therapy with a positioning orifice
Number of subjects: 0
Study: 8290457

Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution undiluted
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Povidone-iodine solution 1:10
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Octenidine 0.1%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.1%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexetidine 0.1%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.05%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All procedures except chlorhexidine 0.05% after 30 minutes
Number of subjects: 6
Study: 3522510

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 60
Study: 30043979

Group type: EXPERIMENTAL
Intervention: Lozenges containing specific IgY against P. gingivalis gingipains
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo lozenges (sham-immune IgY)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups (test and placebo)
Number of subjects: 64
Study: 27311914

Group type: EXPERIMENTAL
Intervention: EEG-guidance of anaesthetic agent administration
Number of subjects: 1232

Group type: COMPARATOR
Intervention: General anaesthesia with clinicians blinded to EEG monitoring
Number of subjects: 1232
Study: 24516192

Group type: EXPERIMENTAL
Intervention: Upstream clopidogrel treatment prior to catheterisation laboratory arrival
Number of subjects: 423

Group type: COMPARATOR
Intervention: No upstream clopidogrel treatment
Number of subjects: 423
Study: 23210197

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) gel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Metronidazole (MTZ) gel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-Metronidazole (CHX-MTZ) gel
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 120
Study: 20208382

Group type: EXPERIMENTAL
Intervention: Supervised cardiac rehabilitation (CR) for 6 months
Number of subjects: 111
Study: 19099126

Group type: EXPERIMENTAL
Intervention: Prednisone 2 mg/kg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prednisone 1 mg/kg/day
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prednisone tapering to 0.5 mg/kg/day or less in one month
Number of subjects: 21
Study: 16026380

Group type: EXPERIMENTAL
Intervention: Pioglitazone monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pioglitazone + sulphonylurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin + sulphonylurea
Number of subjects: 0
Study: 12032792

Group type: EXPERIMENTAL
Intervention: Auditory, tactile, visual, and vestibular (ATVV) intervention
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (nonexposed and drug-exposed)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Experimental group (nonexposed and drug-exposed)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (nonexposed)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Experimental group (nonexposed)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Experimental group (drug-exposed)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combined drug-specific groups (control+experimental)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Experimental group (cocaine-exposed)
Number of subjects: 117
Study: 10485539

Group type: EXPERIMENTAL
Intervention: Granisetron 20 microg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Granisetron 40 microg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Granisetron 80 microg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 8914038

Group type: EXPERIMENTAL
Intervention: i.v. iron dextran 5 ml every 2 weeks
Number of subjects: 37

Group type: COMPARATOR
Intervention: oral ferrous sulphate 200 mg tds
Number of subjects: 37

Group type: COMPARATOR
Intervention: no iron
Number of subjects: 37
Study: 1878232

Group type: EXPERIMENTAL
Intervention: Intramuscular piritramide (7.5 to 15 mg as needed)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous PCA with fentanyl (demand dose 34 micrograms)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous PCA with buprenorphine (demand dose 80 micrograms)
Number of subjects: 60
Study: 6751238

Group type: EXPERIMENTAL
Intervention: Oral theophylline and salbutamol combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral theophylline alone
Number of subjects: 0
Study: 31519683

Group type: EXPERIMENTAL
Intervention: Operative treatment (surgery with suture anchors)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-operative treatment
Number of subjects: 60
Study: 27862660

Group type: EXPERIMENTAL
Intervention: TAU plus body and movement-oriented intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 70
Study: 25275701

Group type: EXPERIMENTAL
Intervention: EBUS‐TBNA
Number of subjects: 110

Group type: COMPARATOR
Intervention: EUS‐FNA
Number of subjects: 110
Study: 24739996

Group type: EXPERIMENTAL
Intervention: Macintosh laryngoscope
Number of subjects: 14

Group type: COMPARATOR
Intervention: Airtraq laryngoscope
Number of subjects: 14
Study: 21138358

Group type: EXPERIMENTAL
Intervention: Ketorolac adhesive film (30 mg) applied over the surgical site immediately after surgery.
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group received adhesive film without KT initially, followed by KT adhesive film applied after 2 hours.
Number of subjects: 68
Study: 19691426

Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Sitagliptin 200 mg once daily
Number of subjects: 103
Study: 17847764

Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRHa) continuously administered for 12 days after embryo transfer
Number of subjects: 181

Group type: COMPARATOR
Intervention: GnRH agonist (GnRHa) stopped on the day of human chorionic gonadotropin administration
Number of subjects: 181
Study: 17147756

Group type: EXPERIMENTAL
Intervention: Falls prevention strategies not involving behaviour change
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multifactorial falls prevention packages
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Consultation with individual potential participants
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Expensive falls prevention programs
Number of subjects: 24
Study: 11746330

Group type: EXPERIMENTAL
Intervention: Treatment A (specific treatment not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment B (specific treatment not mentioned)
Number of subjects: 0
Study: 9052899

Group type: EXPERIMENTAL
Intervention: Low sodium intake (20 mmol NaCl/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular sodium intake (210 mmol NaCl/d)
Number of subjects: 0
Study: 8238214

Group type: EXPERIMENTAL
Intervention: Silicone oil
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Long-acting gas
Number of subjects: 404

Group type: COMPARATOR
Intervention: No retinotomy
Number of subjects: 404
Study: 2962878

Group type: EXPERIMENTAL
Intervention: Dopaminergic agonist co-dergocrine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective D-2 dopamine receptor blocker sulpiride
Number of subjects: 0
Study: 31117218

Group type: EXPERIMENTAL
Intervention: 10 g lactitol
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: 3.5 g psyllium
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Combination of 10 g lactitol and 3.5 g psyllium
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 29879268

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline alone (Control)
Number of subjects: 80
Study: 27769826

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-containing mouthwash
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 17
Study: 24114746

Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (filler task)
Number of subjects: 0
Study: 23137493

Group type: EXPERIMENTAL
Intervention: HeartNet (Paracor Medical) plus optimal heart failure drug and device therapy
Number of subjects: 272

Group type: COMPARATOR
Intervention: Optimal drug and device therapy alone
Number of subjects: 272
Study: 20140826

Group type: EXPERIMENTAL
Intervention: High-frequency miniprobes (HFPs)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional radial endoscopic ultrasonography (crEUS)
Number of subjects: 43
Study: 18706826

Group type: EXPERIMENTAL
Intervention: Bedside Entertainment Services (BES)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No Bedside Entertainment Services (Control)
Number of subjects: 100
Study: 15729158

Group type: EXPERIMENTAL
Intervention: Experimental cues (locations, role relationships, network ties, first letters of names)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: First-name cues
Number of subjects: 123

Group type: COMPARATOR
Intervention: Individual characteristics cues
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Nonspecific prompting and reading back the list
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Supplementary techniques
Number of subjects: 123
Study: 12815681

Group type: EXPERIMENTAL
Intervention: In vivo black blood MRI
Number of subjects: 37
Study: 10555794

Group type: EXPERIMENTAL
Intervention: Polyglactin 910-polydioxanon (PPP) used for reconstruction of the orbital roof
Number of subjects: 144

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 144
Study: 8646706

Group type: EXPERIMENTAL
Intervention: PAPNET
Number of subjects: 7

Group type: COMPARATOR
Intervention: Conventional screening
Number of subjects: 7
Study: 14766525

Group type: EXPERIMENTAL
Intervention: Intertask processing
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intratask processing
Number of subjects: 48

Group type: COMPARATOR
Intervention: No additional processing
Number of subjects: 48
Study: 6305244

Group type: EXPERIMENTAL
Intervention: Acyclovir, 5 mg/kg body weight at 8‐hour intervals for 5 days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 31
Study: 30946349

Group type: EXPERIMENTAL
Intervention: 5 cmH2O of PEEP
Number of subjects: 50

Group type: COMPARATOR
Intervention: Zero‐PEEP (ZEEP)
Number of subjects: 50
Study: 30223563

Group type: EXPERIMENTAL
Intervention: LFD and TP arm (80 g of TP/day) for seven days
Number of subjects: 19

Group type: COMPARATOR
Intervention: LFD-only control arm
Number of subjects: 19
Study: 26650831

Group type: EXPERIMENTAL
Intervention: Ultrasound (US)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 182
Study: 24482313

Group type: EXPERIMENTAL
Intervention: OM-89
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 21947318

Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21146672

Group type: EXPERIMENTAL
Intervention: Spironolactone at discharge
Number of subjects: 946

Group type: COMPARATOR
Intervention: No spironolactone at discharge
Number of subjects: 946
Study: 17931902

Group type: EXPERIMENTAL
Intervention: Manipulation under anesthesia
Number of subjects: 125

Group type: COMPARATOR
Intervention: Home exercises alone (control)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups (manipulation and control)
Number of subjects: 125
Study: 15981671

Group type: EXPERIMENTAL
Intervention: 99mTc-DTPA aerosol scintigraphy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (fifteen healthy voluntary controls)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CO-diffusion parameters
Number of subjects: 22
Study: 12873959

Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL normal saline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hypobaric bupivacaine (3.5 mL, 17.5 mg mixed with 1.5 mL distilled water)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isobaric bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hypobaric bupivacaine
Number of subjects: 40
Study: 10573245

Group type: EXPERIMENTAL
Intervention: Venturi masks (VMs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nasal prongs (NPs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Both VMs and NPs
Number of subjects: 18
Study: 8671270

Group type: EXPERIMENTAL
Intervention: Interceed absorbable adhesion barrier
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (untreated ovaries)
Number of subjects: 25
Study: 1882661

Group type: EXPERIMENTAL
Intervention: 1-mg gemeprost (Cervagem) pessary
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 6341159

Group type: EXPERIMENTAL
Intervention: Golytely (an electrolyte‐polyethylene glycol solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 2- and 3-day bowel preparations
Number of subjects: 0
Study: 29606196

Group type: EXPERIMENTAL
Intervention: Forest bathing group (forest)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urban control group (city)
Number of subjects: 0
Study: 27439012

Group type: EXPERIMENTAL
Intervention: Systematic Community Engagement (SCE) intervention
Number of subjects: 234

Group type: COMPARATOR
Intervention: Financial incentives
Number of subjects: 234
Study: 26083963

Group type: EXPERIMENTAL
Intervention: Stunted patients (height-for-age Z score < -2)
Number of subjects: 2542

Group type: COMPARATOR
Intervention: Non-stunted patients (height-for-age Z score >= -2)
Number of subjects: 2542

Group type: EXPERIMENTAL
Intervention: Stunted patients with hypoxaemic pneumonia
Number of subjects: 2542
Study: 23403476

Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 20626604

Group type: EXPERIMENTAL
Intervention: Mirodenafil 100 mg on demand for 12 weeks
Number of subjects: 112
Study: 18852533

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 1000 mg every 6 to 9 weeks for 30 weeks, then 1000 mg every 12 weeks for 114 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Testosterone enanthate (TE) 250 mg every 3 weeks for 30 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 1000 mg every 12 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) and Testosterone enanthate (TE)
Number of subjects: 40
Study: 17321921

Group type: EXPERIMENTAL
Intervention: Topographic method for ETT insertion depth
Number of subjects: 200

Group type: COMPARATOR
Intervention: 21/23 cm insertion depth method (Control)
Number of subjects: 200
Study: 12908943

Group type: EXPERIMENTAL
Intervention: Sweat patch testing
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Drugwipe immunochemical strip test
Number of subjects: 9
Study: 10899655

Group type: EXPERIMENTAL
Intervention: Docetaxel (T)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Sequential methotrexate and 5-fluorouracil (MF)
Number of subjects: 283
Study: 8978519

Group type: EXPERIMENTAL
Intervention: Ergonomic posture training
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Vibration-dampening rivet guns
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 212
Study: 1378143

Group type: EXPERIMENTAL
Intervention: Intravenous carvedilol (12.5 mg in 1 h)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral carvedilol (25 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: R(+) enantiomer
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: S(‐) enantiomer
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Carvedilol and carvedilol glucuronide
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 6
Study: 6689452

Group type: EXPERIMENTAL
Intervention: Clear fluids initially, followed by increasing strengths of milk, in quarter strength steps
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Clear fluids initially and then reintroducing full strength milk
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Continuing full strength milk
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 150
Study: 31092226

Group type: EXPERIMENTAL
Intervention: Combined ACLR and LET
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard single bundle hamstring ACLR
Number of subjects: 600
Study: 29716903

Group type: EXPERIMENTAL
Intervention: Multimodal integrative intervention (relaxation, guided imagery, moderate pressure massage, listening to music)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Multimodal integrative intervention
Number of subjects: 60
Study: 27100788

Group type: EXPERIMENTAL
Intervention: Statin (10 mg daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 25543420

Group type: EXPERIMENTAL
Intervention: Combined therapy (cutting method and western medication)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cutting method
Number of subjects: 120

Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 120
Study: 22632584

Group type: EXPERIMENTAL
Intervention: Lumbar extension traction with stretching exercises and infrared radiation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Stretching exercises and infrared radiation alone
Number of subjects: 80
Study: 19448389

Group type: EXPERIMENTAL
Intervention: Preventive home‐visit intervention (n=122)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (n=121)
Number of subjects: 243
Study: 17560882

Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study: 15076794

Group type: EXPERIMENTAL
Intervention: Commercial herbal-based formula (4 d x 6 caps.d(‐1) loading phase, 11 d x 3 caps.d(‐1) maintenance phase)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 12364430

Group type: EXPERIMENTAL
Intervention: Teriparatide (40 micro g)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Alendronate (10 mg)
Number of subjects: 146
Study: 9846026

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 30 mg three times a day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 8077527

Group type: EXPERIMENTAL
Intervention: Alteplase or streptokinase therapy (group A)
Number of subjects: 7426

Group type: COMPARATOR
Intervention: No reperfusion therapy (group B)
Number of subjects: 7426
Study: 2534679

Group type: EXPERIMENTAL
Intervention: Tetrabenazine (TBZ)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 11
Study: 1126582

Group type: EXPERIMENTAL
Intervention: Aerosol-spray M protein vaccine
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 43
Study: 30578152

Group type: EXPERIMENTAL
Intervention: Darbepoetin
Number of subjects: 590

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 590
Study: 27595389

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS (2Hz, 200ms)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Traditional TENS (80Hz, 200ms)
Number of subjects: 5
Study: 27137146

Group type: EXPERIMENTAL
Intervention: ALO-02 capsule administered whole under fed conditions (high-fat breakfast ∼ 950 calories)
Number of subjects: 24

Group type: COMPARATOR
Intervention: ALO-02 capsule administered whole under fasting conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: ALO-02 pellets sprinkled on applesauce under fasting conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Single 40 mg doses of ALO-02
Number of subjects: 24
Study: 24004645

Group type: EXPERIMENTAL
Intervention: B-vitamins (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 500 μg)
Number of subjects: 8164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8164
Study: 21406699

Group type: EXPERIMENTAL
Intervention: 35% urea in a water-lipid-based foam containing lactic acid
Number of subjects: 12
Study: 19441985

Group type: EXPERIMENTAL
Intervention: Novel median-approach microendoscopic laminectomy
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional laminectomy
Number of subjects: 41
Study: 17197015

Group type: EXPERIMENTAL
Intervention: Website-delivered physical activity intervention with repeated feedback
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Website-delivered physical activity intervention without repeated feedback
Number of subjects: 434

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 434